Pre-mercato: 164.00 0.21 +0.13%

Abbvie Inc (ABBV)

Abbvie Inc Borsa (ABBV) Ultime notizie

Abbvie Inc (ABBV)

Abbvie Inc Borsa (ABBV) Ultime notizie

Earnings call: AbbVie projects robust growth and diversified pipeline - Investing.com

AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch

AbbVie Unit Protects 'Juvéderm' Cosmetics TM At EU Court - Law360

AbbVie takes option on Gilgamesh CNS drugs in $2bn deal - pharmaphorum

Pfizer: Best Trading Momentum Since 2021 And 6% Yield

Healthcare Deals This Week: AbbVie, Takeda And More - Law360

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh - Scrip

AbbVie Inc. stock rises Tuesday, still underperforms market - MarketWatch

Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In

AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup - MedCity News

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal

AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal - Zacks Investment Research

AbbVie makes psychedelic play with $2bn Gilgamesh collaboration - Pharmaceutical Technology

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - Yahoo Finance

White & Case Secures Victory for AbbVie Inc. and Other Pharmaceutical Companies in the US Court of Appeals for the ... - White & Case LLP

AbbVie and Gilgamesh Commit to Innovative Psychiatric Solutions - The Dales Report

3 Magnificent Stocks That Are Passive Income Machines

AbbVie Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

AbbVie, Gilgamesh Pharmaceuticals enter psychiatric drug deal - Crain's Chicago Business

AbbVie, Gilgamesh to develop next-generation psychedelic drugs (NYSE:ABBV) - Seeking Alpha

What Is the Dividend Payout for AbbVie Stock? - Yahoo Finance

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next ... - PR Newswire

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech

Earn $1000 Every Month From These 3 Stocks

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates

3 Rock-Solid Dividend Stocks That Are Ideal for Retirees

TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up

AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

AbbVie Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Transforming Cancer Care from the Inside Out - AbbVie

Rexulti the surprise winner in April's TV drug ad spending list - FiercePharma

3 Top Dividend Stocks to Maximize Your Retirement Income

Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?

AbbVie Inc. stock underperforms Monday when compared to competitors - MarketWatch

3 Reasons to Buy AbbVie Stock on the Dip

3 Reasons to Buy AbbVie Stock on the Dip - Yahoo Finance

Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight - Yahoo Finance

Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

AbbVie Inc. stock outperforms competitors despite losses on the day - MarketWatch

AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is WisdomTree U.S. Quality Dividend Growth ETF (DGRW) a Strong ETF Right Now?

Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock - Zacks Investment Research

AbbVie (ABBV) Could Be a Great Choice

AbbVie Foundation - AbbVie

3 Top Dividend Stocks to Maximize Your Retirement Income

Simile a ABBV